ART-101 (Scancell)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameART-101 (Scancell)
Drug Alias NameSC 101SC-101ART-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Lewis-Y antigen
TargetsLewis-Y antigen
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScancell Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScancell Ltd
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A